23 09, 2021 Paola Ulivi et al., Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience adlitterio663392022-10-14T12:06:12+02:00 Mehr erfahren
21 09, 2021 Carla Debernardi et al., Correction to: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction adlitterio663392022-10-21T09:22:20+02:00 Mehr erfahren
19 08, 2021 Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC adlitterio663392022-10-21T09:20:25+02:00 Mehr erfahren
18 07, 2021 Alessandro Parisi et al., Clinicians‘ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, „Real-Life“, Case-Control Study adlitterio663392022-10-21T09:31:53+02:00 Mehr erfahren
12 03, 2021 Giada Munari et al., Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience adlitterio663392022-10-21T15:54:12+02:00 Mehr erfahren
18 02, 2021 Silvia Nicolini et al., Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors adlitterio663392022-10-21T16:01:03+02:00 Mehr erfahren
28 01, 2021 Anna Caterina Milanetto et al., Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature adlitterio663392022-10-21T16:07:11+02:00 Mehr erfahren
6 01, 2021 Elena Lastraioli et. al., KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation Diatech Pharmacogenetics2021-11-03T17:07:30+01:00 Mehr erfahren
7 12, 2020 Annamaria Siggillino et. al., Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR. Diatech Pharmacogenetics2020-12-07T16:31:14+01:00 Mehr erfahren
7 12, 2020 Annamaria Siggillino et. al., Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR Diatech Pharmacogenetics2020-12-07T12:32:21+01:00 Mehr erfahren
